Primary antibodies used in this research were anti-mouse α-SMA (Diagnostic Biosystems, Pleasanton, CA); anti-mouse nestin (Developmental Studies Hybridoma Bank, University of Iowa, Iowa City, IA); anti-rabbit Musashi 1 and neurofilament-200 (Millipore, Billerica, MA); and anti-goat ΔN p63, anti-goat SOX 2, anti-goat PAX 6, anti-goat CHX 10, anti-rabbit ABCG2, anti-rabbit adenylate cyclase II, anti-mouse α-actinin, normal goat IgG, normal mouse IgG2a and normal rabbit IgG (Santa Cruz Biotechnology, Inc., Santa Cruz, CA), as well as an antibody against AE1/AE3, a pan-cytokeratin marker (BD Biosciences, San Jose, CA), an antibody against vimentin (Sigma Aldrich, St. Louis, MO) and anti-mouse Ki-67 (Vector Laboratories, Burlingame, CA). We also used secondary antibodies Cy2 anti-mouse, Cy3 anti-rabbit, and Cy3 anti-goat (Jackson Immunoresearch Labs, Inc., West Grove, PA); RPMI-1640, X-VIVO 15, KBM cell culture media and KBM supplements (Lonza, Walkersville, MD); and corneal endothelial cell medium (a kind gift from Dr Nancy Joyce, Schepens Eye Research Institute). In addition, we used fetal bovine serum (Hyclone Laboratories, Logan, UT), EGF (Peprotech, Rocky Hill, NJ),The neuronal media supplements N2 supplement B (Stem Cell Technologies, Tukwila, WA) and B27 (Invitrogen, Carlsbad, CA). Tissue culture plastics and pipettes were from VWR International (Radnor, PA) and Fisher Scientific (Pittsburgh, PA). All reagents, unless otherwise specified were from Sigma-Aldrich Corp. (St. Louis, MO).